Role of Intestinal Bacteria in Gliadin-Induced Changes in Intestinal Mucosa
Author Information
Author(s): Cinova Jana, De Palma Giada, Stepankova Renata, Kofronova Olga, Kverka Miloslav, Sanz Yolanda, Tuckova Ludmila
Primary Institution: Institute of Microbiology v.v.i., Academy of Sciences of the Czech Republic
Hypothesis
The study aimed to investigate the effects of gliadin and various intestinal bacterial strains on mucosal barrier integrity, gliadin translocation, and cytokine production.
Conclusion
The composition of the intestinal microbiota affects the permeability of the intestinal mucosa and could be involved in the early stages of celiac disease pathogenesis.
Supporting Evidence
- Gliadin fragments decreased the number of goblet cells in the small intestine.
- The presence of E. coli and Shigella further reduced goblet cell numbers.
- Bifidobacterium bifidum increased goblet cell numbers when combined with gliadin.
- Cytokine levels were altered in response to bacterial strains and gliadin.
Takeaway
This study shows that certain bacteria in the gut can change how gliadin, a protein in gluten, affects the intestines, which might help explain celiac disease.
Methodology
The study used germ-free rats to assess changes in gut mucosa after exposure to gliadin and various bacterial strains through histology, scanning electron microscopy, and cytokine analysis.
Potential Biases
Potential bias may arise from the use of specific bacterial strains and the controlled environment of germ-free conditions.
Limitations
The study was conducted in germ-free rats, which may not fully replicate the complex interactions in a normal gut environment.
Participant Demographics
Germ-free Wistar-AVN rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website